Showing results (121-130 of 158) with videos related to
Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology. in Practice|July 20, 2024
Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil CountsJohn Busby, Shruti Menon, Neil Martin, et al.Respiratory Research|April 29, 2021
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbationsDave Singh, Gerard J Criner, Mark T Dransfield, et al.American Journal of Respiratory and Critical Care Medicine|April 4, 2023
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical TrialsJonathan Corren, Andrew Menzies-Gow, Geoffrey Chupp, et al.European Urology Oncology|July 24, 2023
Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental CohortKendrick Yim, Shu-Hui Hsu, José Ignacio Nolazco, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 2, 2022
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT TrialAndrea Gabrio, Necdet B Gunsoy, Gianluca Baio, et al.The Lancet. Respiratory Medicine|November 29, 2025
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trialDavid J Jackson, Njira L Lugogo, Mark Gurnell, et al.International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.ERJ Open Research|March 15, 2021
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysisMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.Advances in Radiation Oncology|May 11, 2026
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution ExperienceShane S Neibart, Katie N Lee, Yu-Hui Chen, et al.Respiratory Research|June 7, 2020
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trialNicola C Day, Subramanya Kumar, Gerard Criner, et al.Pageof 16